| Followers | 0 |
| Posts | 415 |
| Boards Moderated | 0 |
| Alias Born | 02/17/2017 |
Friday, July 28, 2017 7:29:37 PM
Interesting assessment of Sparks "testimony" by "risingskeptic" on seekingalpha:
"And pardon me for saying I ALSO find THIS just before the earnings call HIGHLY SUSPICIOUS:
https://twitter.com/TheHarryx1/status/890629457467260928/photo/1
Out of NOWHERE this Paul Sparks guy brings up using inhaled insulin before a senate committee AND the senator OBLIGES by asking for more details? And THEN the guy delivers what sounds like a script straight from an afrezza publicist?
He even mentions "Aaron Kowalski, who is Chief Mission Officer for JDRF"! Where did THAT come from?
No, I think maybe some silver crossed some palms somewhere!"
"And pardon me for saying I ALSO find THIS just before the earnings call HIGHLY SUSPICIOUS:
https://twitter.com/TheHarryx1/status/890629457467260928/photo/1
Out of NOWHERE this Paul Sparks guy brings up using inhaled insulin before a senate committee AND the senator OBLIGES by asking for more details? And THEN the guy delivers what sounds like a script straight from an afrezza publicist?
He even mentions "Aaron Kowalski, who is Chief Mission Officer for JDRF"! Where did THAT come from?
No, I think maybe some silver crossed some palms somewhere!"
Recent MNKD News
- MannKind to Host Conference Call Today to Discuss Afrezza Pediatric Approval • GlobeNewswire Inc. • 05/29/2026 06:00:00 PM
- MannKind Announces FDA Approval of Afrezza®, the First and Only Inhaled Mealtime Insulin for Use in Children and Adolescents Aged 6 and Older Living with Diabetes • GlobeNewswire Inc. • 05/29/2026 04:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2026 12:37:11 PM
- MannKind to Showcase New Data at ADA 2026 Advancing Understanding of Inhaled Insulin (Afrezza®) in Pediatric Care, Pregnancy and Use with Automated Insulin Delivery (AID) Systems • GlobeNewswire Inc. • 05/27/2026 01:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2026 01:10:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2026 01:00:01 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2026 12:56:12 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2026 12:52:40 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2026 12:51:22 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2026 12:50:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2026 12:49:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2026 12:48:42 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2026 12:48:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2026 12:47:16 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 09:17:49 PM
- Form 144/A - Report of proposed sale of securities: [Amend] • Edgar (US Regulatory) • 05/14/2026 08:51:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 12:30:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 12:30:03 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/12/2026 08:34:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/12/2026 08:34:39 PM
- The $59B Quiet Shift Reshaping How Patients Access Care • PR Newswire (Canada) • 05/12/2026 02:30:00 PM
- The $59B Quiet Shift Reshaping How Patients Access Care • PR Newswire (US) • 05/12/2026 02:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2026 08:05:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 08:03:30 PM
- MannKind Reports First Quarter 2026 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/06/2026 08:01:00 PM
